Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 3/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL30441965 | 0.77 | SCN1A (0.34) | — | |
| SCHEMBL1191609 | 0.72 | TP53 (0.31) | — | |
| SCHEMBL11702536 | 0.72 | CYP1A2 (0.58) | CYP1A2MAPK1DPP4 | |
| SCHEMBL30173247 | 0.71 | KDM4E (0.33) | — | |
| SCHEMBL20000110 | 0.71 | CYP1A2 (0.90) | CYP1A2MAPK1DPP4 | |
| SCHEMBL18072159 | 0.69 | CYP1A2 (0.50) | CYP1A2MAPK1DPP4 | |
| SCHEMBL5913713 | 0.69 | ALDH1A1 (0.32) | MAPK1 | |
| SCHEMBL28371972 | 0.67 | ALDH1A1 (0.31) | — | |
| SCHEMBL236516 | 0.66 | CYP1A2 (1.00) | CYP1A2MAPK1DPP4 | |
| SCHEMBL17873202 | 0.66 | CYP1A2 (0.56) | CYP1A2MAPK1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190211256-A1 | SULFONATED IMINODIALKANOIC ACIDS FORMED FROM AN IMINODIALKYLNITRILE AND A SULTONE AND METHODS FOR USE THEREOF | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211256-A1 | SULFONATED IMINODIALKANOIC ACIDS FORMED FROM AN IMINODIALKYLNITRILE AND A SULTONE AND METHODS FOR USE THEREOF | STS, TST, SI | CYP1A2 3826/4885MAPK1 3611/4885DPP4 2355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.